Provided by Tiger Trade Technology Pte. Ltd.

Milestone Pharmaceuticals Inc.

1.03
-0.0208-1.97%
Volume:557.71K
Turnover:575.43K
Market Cap:128.24M
PE:-1.53
High:1.06
Open:1.06
Low:1.02
Close:1.06
52wk High:3.06
52wk Low:1.00
Shares:124.00M
Float Shares:106.47M
Volume Ratio:1.88
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6748
EPS(LYR):-0.7517
ROE:-35522.62%
ROA:-42.78%
PB:7.04
PE(LYR):-1.38

Loading ...

Aug 12, 2026

Major Issues Report

Form 8-K - Current report
Aug 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jun 16, 2026

Major Issues Report

Form 8-K - Current report
May 20, 2026

Correspondence

Form CORRESP - Correspondence
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Major Issues Report

Form 8-K - Current report
May 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 20, 2026

Major Issues Report

Form 8-K - Current report
Mar 20, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 13, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Major Issues Report

Form 8-K - Current report
Dec 15, 2025

Major Issues Report

Form 8-K - Current report
Nov 12, 2025

Major Issues Report

Form 8-K - Current report
Nov 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]